December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Recombinant Human CT-1 Protects Photoreceptors in Transgenic Rats with Rhodopsin Mutation S334ter
Author Affiliations & Notes
  • Y Song
    Department of Ophthalmology University of Pennsylvania School of Medicine Philadelphia PA
  • L Zhao
    Department of Ophthalmology University of Pennsylvania School of Medicine Philadelphia PA
  • M Jiang
    Department of Ophthalmology University of Pennsylvania School of Medicine Philadelphia PA
  • AM Laties
    Department of Ophthalmology University of Pennsylvania School of Medicine Philadelphia PA
  • W Tao
    Neurotech USA Lincoln RI
  • R Wen
    Department of Ophthalmology University of Pennsylvania School of Medicine Philadelphia PA
  • Footnotes
    Commercial Relationships   Y. Song, None; L. Zhao, None; M. Jiang, None; A.M. Laties, None; W. Tao, None; R. Wen, None. Grant Identification: Support: NIH Grant EY12727, the Foundation Fighting Blindness, the Karl Kirchgessner Foundation.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3950. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y Song, L Zhao, M Jiang, AM Laties, W Tao, R Wen; Recombinant Human CT-1 Protects Photoreceptors in Transgenic Rats with Rhodopsin Mutation S334ter . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3950.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: CNTF and CLC, two members of the IL6 family of cytokines, protect photoreceptors in several animal models of retinal degeneration. In the present study, we examined CT-1 (cardiotrophin-1), another cytokine of this family, for its potential to protect photoreceptors in a line of transgenic rats (S334ter-3 rats) carrying a murine rhodopsin mutation S334ter. Methods: CT-1 cDNA was cloned by PCR from a human heart cDNA pool and expressed in E. coli. Recombinant protein was purified under native conditions. Heterozygous S334ter-3 rats were used in all experiments. The left eye of an animal was injected with 2 µg of CT-1 protein (in 2 µl PBS) intravitreally every three days starting at PD9. The right eye was injected with 2 µl of PBS in the same fashion. Eyes were collected at PD21 or 30, and retinas were examined histologically to evaluate photoreceptor survival. For immunoblot analysis, retinas were collected 0.5, 1, 2, 6, 12, 24, and 48 hours after a single intravitreal injection of 2 µg of CT-1 protein (in 2 µl PBS) at PD9. Total protein from each retina was subjected to SDS-PAGE. Phosphorylated Stat3 was detected using phospho-Stat3 specific antibodies. Results: In untreated animals most photoreceptors die from PD8 through PD20. The peak of photoreceptor death occurs on PD11 and 12. In PBS injected control eyes at PD21, there is only one row of nuclei in the ONL in the superior retina, and 1-2 rows in the inferior retina, similar to the untreated eyes. In CT-1 treated eyes at PD21, there are 5-6 rows of nuclei in the ONL in both the superior and the inferior retina. At PD30, the PBS injected eyes have 0-1 row of nuclei in the ONL in the entire retina. The CT-1 treated eyes, however, still have 5-6 rows. Immunoblot analysis shows a remarkable increase in Stat3 phosphorylation a single injection of CT-1 at PD9. The increase is observed as early as 30 min after injection, and lasts for 24 hr. A slight increase in Stat3 phosphorylation is also observed in PBS injected retinas 30 min to 12 hr after injection. Conclusion: Intravitreal injection of recombinant human CT-1 protein protects photoreceptors and this protection is extended by repeated dosing. Since CT-1 is a member of the IL6 family of cytokines, along with CNTF and CLC, our results likely indicate a common mechanism through which these cytokines protect photoreceptors from degeneration.

Keywords: 517 photoreceptors • 489 neuroprotection • 380 cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×